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Review
The purpose and intent of this retrospective per-
formance assessment was to review the history 
of developmental neurotoxicity (DNT) testing. 
This review demonstrates the extensive scientific 
efforts, including basic neuro  toxicology research, 
interlaboratory collaborative studies, expert 
workshops, and validation studies, that form the 
foundation for this testing paradigm. We also 
review the relevance, applicability, and use of the 
DNT study in human health risk assessment and 
the historical performance of the DNT study. 
This analysis was developed by an OECD expert 
group [Organisation for Economic Co-operation 
and Development (OECD) 2008a] in support 
of drafting the OECD DNT Test Guideline 
426 (TG 426; OECD 2007) that satisfies cur-
rent OECD validation criteria.
OECD validation criteria are described 
in Guidance Document 34 (GD34; OECD 
2005a), which addresses the validation and 
regulatory acceptance of new or updated test 
methods for hazard characterization. They are 
based on the “Solna Principles” for validation 
and regulatory acceptance (OECD 1996b), 
but additionally emphasize the importance of 
flexibility and adaptability in the validation 
process without compromising scientific rigor.
GD34 (OECD 2005a) also provides 
concise definitions of related concepts such as 
accuracy, concordance, performance standards, 
predictivity, relevance, reliability, repeatabil-
ity, reproducibility, sensitivity, and specificity. 
The terminology and definitions presented in 
GD34 (Annex 1) were used in the DNT review 
process; however, individual studies may have 
varied slightly in the definition of terms.
The first DNT guideline was devel-
oped by the U.S. Environmental Protection 
Agency (EPA) and has been subjected to 
numerous validation studies and rigorous 
peer reviews over the years. The U.S. EPA has 
deemed the method validated for its regula-
tory purposes. As described herein, extensive 
supportive materials for the relevance, reli-
ability, and overall performance of the DNT 
study are available. Until recently, only the 
U.S. EPA DNT guideline has been avail-
able for testing laboratories. The new OECD 
TG 426 (OECD 2007) DNT guideline 
will fill a regulatory gap for OECD member 
countries. This review summarizes the con-
siderable work that has been performed in the 
development of the DNT study and provides 
the rationale for the regulatory acceptance of 
TG 426 as a new OECD test guideline.
The U.S. EPA DNT guideline (U.S. 
EPA 1998), the prototype for TG 426, was 
founded upon an extensive scientific data-
base. This includes interlaboratory validation 
studies, such as the Collaborative Behavioral 
Teratology Study (CBTS), which was con-
ducted in the mid-1980s. A separate group 
of experts at the Williamsburg Workshop 
(Kimmel et al. 1990) agreed that the meth-
ods in the DNT study are sensitive to known 
human developmental neurotoxicants. An 
expert consultation meeting conducted in 
2000 (OECD 2003) discussed issues on vali-
dation, especially of individual test compo-
nents versus the whole DNT test method. In 
doing so, they reviewed the extensive history 
of international validation, peer review, and 
evaluation of DNT methods contained in the 
public record. Experts agreed that individual 
assays of the DNT test method have been 
shown to be relevant, reliable, and sensitive 
and that extensive information demonstrates 
the validity of individual components of the 
DNT test method (OECD 2003).
The field of developmental neuro-
toxicology evolved from the disciplines of 
neurotoxicology, experimental and develop-
ment psychology, and developmental 
toxicology, through an extensive history of sci-
entific research and regulatory consideration. 
Developmental toxicity is defined in GD43 
(OECD 2008b), which states that effects may 
result from either prenatal or postnatal expo-
sure, may manifest at any life stage, and may 
be expressed as functional deficits.
The DNT study is a specialized type of 
developmental toxicity study designed to 
screen for adverse effects of pre- and postnatal 
exposure on the development and function 
of the nervous system and to provide dose–
response characterizations of those outcomes. 
The U.S. EPA and OECD DNT guidelines 
recommend administration of the test sub-
stance during gestation and lactation. Cohorts 
of offspring (typically rat) are randomly 
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selected from control and treated litters for 
evaluations of gross neurologic and behav-
ioral abnormalities during postnatal develop-
ment and adulthood (OECD 2007; U.S. EPA 
1998). These include assessments of physi-
cal development, behavioral ontogeny, motor 
activity, motor and sensory function, learning 
and memory, and postmortem evaluation of 
brain weights and neuropathology.
History of DNT Test Guideline 
Development
The evolution of DNT studies has its roots 
in scientific publications that began to appear 
in the early 1960s; the science has contin-
ued to develop over the past four decades. 
An extensive scientific literature, composed of 
studies evaluating the potential for physical, 
pharmaceutical, and environmental agents to 
affect the development and function of the 
nervous system after prenatal and early post-
natal exposure, provides a strong foundation 
for guideline development, implementation, 
and validation. Table 1 lists some of the key 
contributions to the development of the DNT 
guidelines. Table 2 briefly summarizes the his-
tory of U.S. EPA and OECD DNT guideline 
development. Although prenatal developmen-
tal toxicity test guidelines have existed for 
some time (e.g., OECD 1983), the first regu-
latory protocol designed to evaluate DNT was 
developed and implemented by the U.S. EPA 
in support of hazard evaluation for specific 
solvents (U.S. EPA 1986), and a DNT guide-
line applicable to the evaluation of both toxic 
substances and pesticides was finalized in 1991 
(U.S. EPA 1991). In 1998, it was revised (U.S. 
EPA 1998) as part of a broader U.S. effort to 
harmonize testing guidelines within U.S. EPA 
program offices and with the OECD.
In 1995, the OECD initiated the devel-
opment of the DNT TG 426 (OECD 1995). 
The first draft of TG 426 was prepared after 
an expert consultation meeting (OECD 
1996a), using the U.S. EPA DNT guide-
line as the design template, and addressed 
a   number of important issues and recom-
mended improvements. The draft TG 426 
Table 1. Historical contributions to the DNT guideline.
Date  Event  Summary  References
1960s–1980s  Published research on DNT and   Evidence that developmental exposure to chemicals  Irwin 1968, Spyker and Smithberg 1972,
    behavioral testing    and drugs can alter behavioral function in young and    Barlow and Sullivan 1975, Butcher et al. 
      adult animals    1979, Butcher and Vorhees 1979, Vorhees
        et al. 1979, Butcher and Nelson 1985,
        Adams 1986
1978–1984  CBTS  Study to examine intra- and interlaboratory reliability  Buelke-Sam et al. 1985,
      and sensitivity of behavioral test methods    Kimmel and Buelke-Sam 1985,
        Kimmel et al. 1985
1984  Cincinnati Test Protocol  Within-laboratory comparison of CBTS test protocol with   Vorhees 1985a, Vorhees 1985b, 
      the Cincinnati Test Protocol    Vorhees 1985c
1982–1985  Collaborative studies of the Japanese  Interlaboratory methods evaluations and assessment of   Tanimura 1986, Tanimura 1992
    Teratology Society    six reference chemicals
1985–1988  European Interlaboratory  Interlaboratory study to assess sensitivity of behavioral   Elsner 1986, Elsner et al. 1986,
    Collaborative Study    test procedures to detect neurotoxicity of methylmercury    Suter and Schon 1986
1989  Williamsburg Workshop  Workshop to evaluate the qualitative and quantitative   Francis et al. 1990, Kimmel et al. 1990
      comparability of animal and human data for DNT
1993–1997  Collaborative studies of the Japanese   Three interlaboratory studies using behavioral teratogens   Tachibana et al. 1996, Tachibana et al. 
    Teratology Society    comparability a core battery of tests    1998, Fukunishi et al. 1998,
        Nishmura et al. 2001
1995   IPCS   Interlaboratory study using neurotoxic chemicals to  Catalano et al. 1997, MacPhail et al. 1997,
        evaluate test validity, reliability, and measurement    Tilson et al. 1997
      variability
2000  ILSI workshop on DNT testing  Workshop to review U.S. EPA DNT behavioral test   Cory-Slechta et al. 2001, Dorman et al. 
      methods, pharmacokinetics, and neuropathology    2001, Garman et al. 2001,
        Mileson and Ferenc 2001
2003  Japanese Interlaboratory Study  Interlaboratory study using neurotoxic chemicals to   Okazaki et al. 2003
      determine sensitivity of behavioral measures
2003  Behavioral Test Methods Workshop  Expert workshop to address design, conduct, and   Slikker et al. 2005
      analysis of behavioral tests for neurotoxicity evaluation
2004–2008  ILSI RSI Working Group  Working group focused on variability, statistical analyses,  Fenner-Crisp et al. 2005, Crofton et al. 
      positive controls, identification and analyses,    2008, Holson et al. 2008
      interpretation of treatment-related effects, and    Raffaele et al. 2008,Tyl et al. 2008 
      application of DNT testing to public health protection
                                
Table 2. History of the DNT guideline.
Date  Event  Reference
1986  U.S. EPA OPPTS published first draft DNT protocol for peer review and public comment  U.S. EPA 1986
1991  U.S. EPA OPPTS published final DNT guideline (§83-6)  U.S. EPA 1991
1995  OECD Working Group on Reproduction and Developmental Toxicity (Copenhagen) recommended   OECD 1995
    development of OECD Developmental Neurotoxicity Test Guideline
1996  OECD expert consultation meeting (Copenhagen) provided recommendations for design of Draft OECD 426  OECD 1996a
1998  U.S. EPA OPPTS issued minor revisions and harmonization of DNT guideline (OPPTS 870.6300)  U.S. EPA 1998
1998  Draft TG 426 submitted to National Coordinators for expert review and comment
2000  OECD expert consultation meeting (Washington) held to review technical issues  OECD 2003
2003  Draft TG 426 submitted to National Coordinators for expert review and comment
2005  OECD expert consultation meeting (Tokyo) convened to respond to remaining comments on Draft TG 426  OECD 2005b
2007  OECD TG 426 approved by WNT; guideline finalized   OECD 2007
WNT, the working group of the National Coordinators of the Test Guidelines Programme.DNT: retrospective performance assessment
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was distributed for comment in 1998, and 
significant technical issues identified by this 
review (e.g., the optimal duration of treat-
ment, direct dosing of preweaning rodents, 
and conduct of morphometric evaluations) 
were further discussed at an expert consul-
tation meeting in 2000 (OECD 2003). A 
revised draft was subsequently circulated for 
review, and comments from OECD member 
countries were addressed at a 2005 expert 
consultation meeting (OECD 2005b). The 
final version of TG 426 was adopted by the 
OECD Council in 2007 (OECD 2007).
In the context of toxicologic screening 
and testing to support human health risk 
assessment and chemical regulatory activities, 
the DNT study fills an information require-
ment that is not satisfied by other OECD test 
guidelines. Notably, it is the only test guide-
line that includes functional, behavioral, and 
anatomical evaluations of the nervous system 
at multiple time points, in test subjects that 
were exposed to test substance during critical 
pre- and early postnatal periods of nervous 
system development. This test method has 
been used extensively in the past two decades 
on a wide variety of chemicals (Table 3).
Scientific Basis of DNT 
Guideline
The test methods recommended in the DNT 
guideline have been extensively reviewed 
and evaluated over the last 25 years. This has 
included the conduct of a number of meetings 
and collaborative studies involving experts 
from academic, industry, regulatory, and pub-
lic interest groups. Pivotal influences and key 
events in the history of the development of 
the DNT guideline (Table 2) include both 
research on test methods development and 
efforts to characterize and document the sen-
sitivity, reliability, and performance of the 
test methods, including a number of intra-
laboratory collaborative efforts. In the 1970s, 
a series of studies were conducted in which 
rats were developmentally exposed to a vari-
ety of xenobiotics and subsequently tested 
during postnatal development using a bat-
tery of neurobehavioral tests (Butcher and 
Vorhees 1979; Vorhees et al. 1979). Other 
laboratories used behavioral and histologic 
batteries, focusing on sensory and motor 
function, in adult rodents exposed to a wide 
variety of neurotoxicants (Pryor et al. 1983; 
Tilson et al. 1979). A large body of research 
has provided an immense database on the 
ability of the functional observational bat-
tery to detect and characterize the effects of 
drugs and environmental chemicals in adult 
and developing animal models (Gad 1982; 
Irwin 1968; Moser et al. 1988). This early 
work was followed by wide-ranging efforts 
to characterize the specificity of these test 
methods and the impact of both organismal 
and experimental factors (e.g., noise, spe-
cies, strain, gender, test history) (Gerber and 
O’Shaughnessy 1986; Levine and Butcher 
1990; MacPhail et al. 1989; Spencer et al. 
1993). Ultimately, the result of more than 
30 years of work in this area is a consensus 
opinion of neuro  toxicologists that proper use 
and interpretation of the data derived from 
these test methods provide unique insight into 
the impact of xenobiotics on the developing 
and adult nervous system [Cory-Slechta et al. 
2001; International Programme on Chemical 
Safety (IPCS) 2001; Tyl et al. 2008].
The development of test methods in 
neuro  toxicology also includes a long history 
of efforts to characterize the inter  laboratory 
reliability and sensitivity of the test meth-
ods now included in the DNT study design. 
An article comparing a learning and reten-
tion method among three laboratories 
(Butcher et al. 1979) was followed by the 
CBTS (Buelke-Sam et al. 1985; Kimmel and 
Buelke-Sam 1985) and the “Williamsburg 
Workshop” on qualitative and quantitative 
comparability of human and animal DNT 
(Kimmel et al. 1990). These efforts addressed 
various aspects of DNT study design and 
conduct, providing a sound scientific basis 
for the test method and its use in hazard 
evaluation. Since the publication of the U.S. 
EPA DNT guideline (U.S. EPA 1991), a 
continued scientific effort has reviewed and 
updated methodologies, for neurotoxicol-
ogy in general and for developmental neuro-
toxicology in particular. Examples of such 
reviews include the IPCS collaborative study 
on neuro  behavioral screening methodolo-
gies (MacPhail et al. 1997), an International 
Life Sciences Institute (ILSI) Risk Science 
Institute (RSI) workshop on Developmental 
Neurotoxicity and Risk Assessment (Mileson 
and Ferenc 2001), a collaborative study on 
neurobehavioral screening in 11 Japanese 
laboratories (Okazaki et al. 2003), and a 
Behavioral Test Methods Workshop (Slikker 
et al. 2005). Descriptions of each of these 
efforts and their contributions to the scien-
tific basis for DNT testing follow.
The CBTS. Several of the test pro-
cedures developed in early behavioral teratol-
ogy studies underwent validation in a large 
interlaboratory effort, the CBTS. This proj-
ect characterized the performance of a stan-
dardized neurodevelopmental test battery in 
six different laboratories after in utero and 
lactational exposure to two known neuro-
toxicants, methylmercury and amphetamine. 
The study examined the intra- and inter-
laboratory reliability and sensitivity of several 
behavioral test methods and the effects of a 
number of other litter- and gender-related 
variables. The peer-reviewed publications that 
resulted from the CBTS included descriptions 
of the background and overview (Kimmel 
and Buelke-Sam 1985), protocol and test 
procedures (Adams et al. 1985b), data entry 
and test systems (Adams et al. 1985c), pre-
liminary research (Adams et al. 1985a), sta-
tistical approach (Nelson et al. 1985), results 
(Buelke-Sam et al. 1985), and implications, 
current applications, and future directions 
(Kimmel et al. 1985). Additionally, the results 
of a workshop held to review the CBTS data 
were published (Butcher and Nelson 1985; 
Geyer and Reiter 1985; Kutscher and Nelson 
1985; Sobotka and Vorhees 1985; Tilson and 
Wright 1985). In a corollary study, many end 
points in the CBTS study were compared 
within one laboratory to an additional set of 
behavioral end points, named the Cincinnati 
Test protocol, using both methylmercury 
and d-amphetamine (Vorhees et al. 1985a, 
1985b). The conclusion was that the effects 
of methylmercury were detected by both the 
CBTS end points and some of the additional 
end points in the Cincinnati Test protocol 
(Vorhees 1985c). The CBTS showed that rep-
licability of data among laboratories using 
a standardized protocol was excellent and 
that both positive effects (e.g., with methyl-
mercury exposure) and the lack of effects (e.g., 
after low-level amphetamine exposure) were 
replicable. The CBTS also demonstrated that 
the DNT test procedures were sufficiently 
sensitive; no more than a 5–20% change from 
control values was required to detect an effect.
The  European  Interlaboratory 
Collaborative Study. In the 1980s, the 
European Interlaboratory Study Group on 
Behavioural Teratology conducted a study of 
behavioral test methods (Alder et al. 1986; 
Elsner 1986; Elsner et al. 1986; Schreiner et al. 
1986; Suter and Schon 1986). Three labora-
tories, one each from industry, academia, and 
government, tested animals perinatally exposed 
to methylmercury. The results indicated that 
behavioral tests were more sensitive than repro-
ductive end points and that automated proce-
dures and measures aimed at specific functional 
capacities were more sensitive than nonspecific 
behavioral measures (Elsner et al. 1986, 1988).
The Williamsburg Workshop. In 1989, the 
U.S. EPA held a workshop on the Qualitative 
and Quantitative Comparability of Human 
and Animal Developmental Neurotoxicity 
Table 3. Number of chemicals studied using 
the U.S. EPA DNT guideline or draft OECD DNT 
guideline.
Chemical class  No. of studies
Industrial chemicals  8
Miscellaneous agentsa 4
Pharmaceuticals  3
Pesticides  73
Positive control chemicals  15
Solvents  7
aFood additives, cigarette smoke, dietary restriction, and 
maternal separation.Makris et al.
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(also known as the “Williamsburg Workshop”) 
to provide scientific input into DNT protocol 
design and to evaluate its appropriateness for 
use in risk assessment (Kimmel et al. 1990). 
Expert scientists from government, industry, 
public interest groups, and academia reviewed 
a range of representative chemicals and envi-
ronmental exposures, including drugs (canna-
bis, cocaine, methadone, and phencyclidine) 
(Hutchings 1990), ethanol (Driscoll et al. 
1990), the anticonvulsant phenytoin (Adams 
et al. 1990), and environmental contami-
nants such as methylmercury (Burbacher et al. 
1990), lead (Davis et al. 1990), polychlori-
nated biphenyls (Tilson et al. 1990), and ion-
izing radiation (Schull et al. 1990). Based on 
data available for these known human devel-
opmental neurotoxicants, the workshop par-
ticipants concluded that DNT methodologies 
were adequate for detecting DNT. A number 
of specific issues directly relevant to design and 
usefulness of DNT studies were extensively 
evaluated by participants (Buelke-Sam and 
Mactutus 1990; Levine and Butcher 1990; 
Stanton and Spear 1990; Tyl and Sette 1990). 
Additionally, workshop participants addressed 
the relationship between biologic end points 
specified by DNT guidelines and adverse find-
ings observed in humans after exposure to the 
developmental neurotoxic agents under con-
sideration. A major conclusion of the work-
shop was that the DNT protocol would have 
identified each of the agents presented at the 
workshop as a potential developmental neuro-
toxicant (Francis et al. 1990), although the 
critical effects and the dose at which the effects 
were observed could vary across species. The 
workshop participants also concluded that the 
laboratory animal is an adequate surrogate 
for humans because many of the biologic and 
behavioral mechanisms underlying these neu-
rologic functions are shared between humans 
and laboratory animals. The predictive power 
of DNT guideline studies was attributed 
largely to the scope of neurobehavioral and 
neuropathologic tests used that can evaluate 
neurologic functions across multiple domains 
(i.e., sensory, motivational/arousal, cognitive, 
and motor).
Collaborative studies of the Japanese 
Teratology Society. The Japanese Teratology 
Society established the Behavioral Teratology 
Meeting as a satellite meeting of the Japanese 
Teratology Society in 1982. This group spon-
sored a number of collaborative studies con-
ducted primarily by pharmaceutical industry, 
and contract laboratories (Tanimura 1985). 
The first effort involved 21 institutions that 
investigated the effects of parametric vari-
ables (water temperature, number of trials) 
on performance in a water T-maze and two-
way shuttle box (Mizutani 1984). This was 
followed by a larger study involving 46 labo-
ratories that investigated the effects of six 
chemicals (chlorpromazine, ethanol, hydroxy-
urea, methyl  azoxymethanol, phenyl  alanine, 
and vitamin A) (Mizutani 1985). These studies 
demonstrated that the T-maze test was reliable, 
but possibly not as sensitive as needed, and sug-
gested the need for more complicated learning 
paradigms for this method (Tanimura 1986). 
Workshops were then held between 1988 and 
1990, with three subgroups: reflexes and sen-
sory function, activity and emotionality, and 
learning (Tanimura 1992). Subsequently, a 
core battery test draft for behavioral develop-
mental toxicity was proposed. Its utility was 
examined with three posi  tive behavioral terato-
gens during 1993–1997: phenytoin (Fukunishi 
et al. 1998; Tachibana et al. 1996), retinoic 
acid (Nishmura et al. 2001), and nicotine 
(Tachibana et al. 1998). The numbers of par-
ticipating laboratories were 32, 28, and 18, 
respectively. It was concluded that the pro-
posed core battery of tests is useful as a method 
to detect postnatal developmental disorders, 
including behavioral dysfunction, in rats.
The IPCS Study. The IPCS collaborative 
study was an interlaboratory evaluation of 
neurobehavioral screening methodologies used 
in adult and DNT studies (MacPhail et al. 
1997; Moser et al. 1997e). A total of eight 
laboratories participated in proficiency stud-
ies (Moser et al. 1997a), and the full study 
evaluated seven neurotoxic positive control 
chemicals [triethyl tin, acrylamide, parathion, 
p,p´- dichlorodiphenyltrichloroethane (DDT), 
toluene, N,N´-methylene bisacrylamide, and 
lead acetate] in adult male rats (Moser et al. 
1997b, 1997c). The study examined variabil-
ity associated with the test methods and rea-
sons for differences. The overall conclusion of 
this extensive study was general “agreement 
across laboratories in terms of their ability 
to detect dose-related changes in behavioral 
end points with prototypic neurotoxic agents” 
(Catalano et al. 1997). The study results were 
also reviewed at a workshop held in 1995 in 
Capri, Italy (Tilson et al. 1997) and were pre-
sented in a symposium at the 1996 meet-
ing of the Society of Toxicology (Moser et al. 
1997d).
ILSI workshop on DNT testing. In 1999, 
ILSI established a working group of scientists 
from government, industry, academia, and 
nonprofit nongovernmental organizations 
(Mileson and Ferenc 2001) that was charged 
with evaluating revisions to the published U.S. 
EPA DNT guideline that were also included 
in the draft OECD TG 426. Some of these 
changes were implemented by the U.S. EPA 
Office of Pesticide Programs (OPP) when it 
issued Data Call-In notices for organophos-
phate pesticides with tolerances (U.S. EPA 
1999b). The revisions included extension of 
the offspring dosing period through to the 
age of weaning, ensuring that the pups are 
exposed to the test substance, increasing the 
number of offspring evaluated neuropatholog-
ically, and collecting   chemical-class–specific 
biomarker data. The extension of the dosing 
period during the lactation period raised sev-
eral issues, specifically in the areas of pharma-
cokinetic/toxicokinetic data needs, behavioral 
testing, and neuropathologic evaluation. 
Overall, the working group agreed that the 
current DNT test protocol was based upon 
solid scientific principles and experience, 
that there were opportunities to revise and 
improve some aspects of the U.S. EPA guide-
line study, and that further research would be 
valuable in providing the scientific basis for 
development of TG 426 (Cory-Slechta et al. 
2001; Dorman et al. 2001; Garman et al. 
2001; OECD 2003). Further considerations 
of methodologic issues related to the conduct 
of the DNT study include an ILSI workshop 
on the direct dosing of preweaning mammals. 
This workshop culminated in a monograph 
on direct dosing that has broad application 
to study design for many areas of research, for 
example, pharmaceuticals, environmental pol-
lutants, and academic research (Moser et al. 
2005; Zoetis and Walls 2003).
The Japanese Interlaboratory Study. An 
interlaboratory evaluation of neurobehavioral 
screening methodologies (used in DNT stud-
ies as well as adult neurotoxicity studies) was 
carried out by 11 safety research laboratories 
in Japan (Okazaki et al. 2003). The study 
examined technical problems in evaluating the 
neurotoxic potential of chemicals, conducting 
a variety of neurobehavioral tests on rats after 
either acute or repeated (28-day) exposure to 
acrylamide or 3,3´-iminodiproprionitrile. All 
laboratories detected neurotoxicity of both 
chemicals. The report identified interlabora-
tory differences in test method sensitivity and 
concluded that it is important to standard-
ize the methods and criteria and to improve 
observers’ skills (Okazaki et al. 2003).
The Behavioral Test Methods Workshop. 
In 2003, a workshop was conducted to dis-
cuss experimental procedures and practices 
that could help enhance the utility of behav-
ioral data as a reliable index of neurotoxicity 
and in the safety evaluation of chemical sub-
stances (Slikker et al. 2005). Workshop par-
ticipants included individuals from all sectors 
of the neuroscience community: academia, 
government, testing laboratories, industry, 
and nonprofit nongovernmental organiza-
tions. Overall conclusions from the workshop 
were that consensus can be reached on the 
fundamentals of behavioral assessment and 
that aspects such as experimental design, test 
method selection, training of technical staff, 
validation, control of confounding factors, 
data variability, data analysis, and data inter-
pretation should be carefully considered in 
the planning and conduct of behavioral safety 
assessment (Slikker et al. 2005).DNT: retrospective performance assessment
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In summary, the scientific basis of the 
DNT test method has been subjected to an 
extensive history of international validation, 
peer review, and evaluation that is contained 
in the public record. Through the various 
collaborative efforts and workshops that have 
been conducted, a number of important con-
clusions have been drawn. The individual test 
methods used in the DNT study have been 
found to be highly relevant for characterizing 
health risks of neurotoxic chemicals and to be 
based on solid scientific principles and expe-
rience. Using exposures to known human 
developmental neurotoxicants, the DNT 
study has been shown to adequately identify 
the potential for adverse effects of chemical 
exposure on neurologic development. The 
intra- and interlaboratory reproducibility, 
reliability, and sensitivity of the DNT test 
method has been established, using a variety 
of test substances.
Use of the DNT Study in Risk 
Assessment
There is a regulatory need for DNT testing to 
support risk assessments in OECD member 
countries. Many pesticides and other chemi-
cals are known to affect the adult nervous 
system, and there are concerns regarding the 
potential for DNT after early-life exposures to 
these substances [National Research Council 
(NRC) 2000]. This is particularly important 
because unique behaviors and activities of chil-
dren place them at greater risk for increased 
exposure to xenobiotics by multiple routes 
(Brent et al. 2004; Weiss et al. 2004). The call 
for a more rigorous assessment of the potential 
for DNT has been issued by scientists from 
multiple and diverse sectors with an interest in 
public health protection.
An examination of the historical and 
potential uses of the DNT study in risk 
assessment is critical to an overall evalua-
tion of its value in protecting human health. 
Currently, the largest collection of DNT 
guideline studies resides with the U.S. EPA 
OPP, which has obtained information on 
DNT for specific pesticides to satisfy regu-
latory mandates (Food Quality Protection 
Act of 1996). The U.S. EPA has furthermore 
engaged in an ongoing scientific analysis and 
discourse regarding the conduct of DNT 
studies, the interpretation of the data from 
these studies, and their regulatory impact.
A review of 12 DNT studies (Makris et al. 
1998) evaluated by the U.S. EPA Office of 
Prevention, Pesticides, and Toxic Substances 
(OPPTS) in support of the registration and/
or use of nine pesticides and three solvents 
was presented to a Scientific Advisory Panel 
in 1998 (U.S. EPA 1999a). For the nine pes-
ticides examined, the analyses demonstrated 
that the DNT study includes sensitive end 
points that are not examined in any other test 
guideline, including prenatal developmen-
tal, reproduction, and neurotoxicity studies 
(OECD 1983, 1997, 2001), thereby enhanc-
ing detection of neurobehavioral and neuro-
pathologic effects in offspring after exposure 
during sensitive periods of neurologic develop-
ment. As a result, the DNT study, when pres-
ent in a chemical database, is often identified 
as a sensitive study and an important source 
of quantitative and qualitative information for 
risk assessment.
DNT data have been shown to be valuable 
in the selection of end points and doses for risk 
assessment (Makris et al. 1998; Rowland et al. 
2007). As might be expected of a study that 
uses short-term exposures (~ 25–40 days) dur-
ing development, where a single exposure dur-
ing a critical period may result in developmental 
insult (Rice and Barone 2000; Rodier 1980, 
1986, 1994), the predominant use of the DNT 
study in pesticide risk assessment has been for 
acute (single dose) reference doses (RfDs) and 
for short-term (1–30 days) and intermediate-
term (1–6 months) nonoccupational exposures, 
which are especially applicable to risk assess-
ments for children. Results from DNT studies 
have also been used in calculating a chronic 
RfD for lifetime exposure to a toxicant when it 
has been shown to be the most sensitive study 
in the toxicology database.
A survey of the use and value of neurobe-
havioral assessment in safety evaluation was 
also conducted by Middaugh et al. (2003). 
This survey included the results of multi-
national studies conducted since 1990 on 
174 compounds, including pharmaceutical 
(81%), agricultural (7%), industrial (1%), 
or undefined (10%) substances. Notably, 
the neurobehavioral screening conducted 
for pharmaceuticals is generally composed 
of developmental and behavioral assessments 
of second-generation (F1) offspring but does 
not address all of the end points assessed in 
a guideline DNT study. Nevertheless, this 
review found that F1 behavioral parameters 
along with other parameters defined the 
chronic no observed effect level (NOEL) 
in 17 of 113 (15%) and solely defined the 
NOEL in 3 of 113 (2.6%) of the studies 
examined. The conclusion was that F1 behav-
ioral parameters sometimes improved on the 
standard toxicologic measures of hazard iden-
tification, providing information on outcomes 
not addressed by other standard measures of 
toxicity.
By early 2006, a review of regulatory and 
published sources revealed that approximately 
114 DNT studies had been completed using 
either the U.S. EPA guideline or the draft 
OECD guideline (Table 4). The list of agents 
in Table 4 demonstrates the extensive history 
and experience regarding the conduct and 
interpretation of DNT studies. The outcomes 
of these efforts do not comprise a focused 
attempt to validate the study protocol or spe-
cific end points. In fact, a few of these studies 
did not include all the end points recom-
mended by U.S. EPA or OECD guidelines.
As of August 2006, approximately 
75 DNT studies had been submitted to the 
U.S. EPA OPP in support of pesticide regis-
tration. A preliminary survey of the use of 
DNT studies in risk assessment in OPP was 
conducted in March 2007 (Rowland et al. 
2007). For 58 of the 75 pesticide chemicals, 
a DNT study had been considered in the 
weight-of-evidence review of the toxicology 
database. The DNT study was used to select 
end points and doses for risk assessments for 
eight of those chemicals. Importantly, for four 
of the eight DNT studies, the critical effects 
either included or were solely based upon off-
spring behavioral and neuropathologic param-
eters that are not evaluated in other guideline 
studies (i.e., motor activity, auditory startle 
habituation, learning and memory, and mor-
phometric analysis). This is consistent with 
the conclusions of the earlier retrospective 
analysis (Makris et al. 1998) and provides 
further evidence of the sensitivity of the DNT 
study in identifying adverse effects in the 
young and the important role of DNT studies 
in human health risk assessments.
In addition to using DNT data for regu-
latory decisions, some regulatory agencies 
have also, on a case-by-case basis, incorpo-
rated an additional database uncertainty fac-
tor into their regulatory decisions because 
of the absence of DNT data. This approach 
reflects regulator views that DNT data are 
valuable in refining permissible exposure lev-
els and that the absence of these data can 
increase the uncertainty about the toxicity of 
the chemicals (U.S. EPA 2002a, 2002b).
Recent reviews have examined specific end 
points across multiple guideline DNT studies, 
to demonstrate the value of current methods 
in hazard characterization and explore fur-
ther opportunities for methodologic refine-
ment. U.S. EPA scientists have conducted 
cross-laboratory comparisons of methodolo-
gies and results from DNT studies submitted 
to OPP (Crofton et al. 1991, 2004; Makris 
et al. 2005, 2006; Raffaele et al. 2003, 2004, 
2005, 2006; Sette et al. 2004). Kaufmann and 
Groters (2006) reviewed the neuropathologic 
assessments in DNT studies, summarized 
practical aspects in planning neuropatho-
logic assessments, and highlighted the value 
of morphology data in reference to both the 
concurrent behavioral assessments and use in 
assessing risk. A multisector ILSI RSI work-
shop examined the evaluation and interpreta-
tion of neurodevelopmental end points for 
human health risk assessment and addressed 
public health considerations, data interpreta-
tion, data variability, positive control data, 
and statistical analysis (Crofton et al. 2008; Makris et al.
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Fenner-Crisp et al. 2005; Holson et al. 2008; 
Raffaele et al. 2008; Tyl et al. 2008).
These various review efforts and result-
ing publications provide transparent decision 
criteria for the analysis and interpretation of 
DNT test results, in accordance with the prin-
ciples described in GD34 (OECD 2005a). 
Additionally, they demonstrate test method 
reliability, reproducibility, and rele  vance, 
which is attributable in part to the high level 
of standardization of the test methods that are 
recommended in the test guideline.
Future Activities
Although the overall performance of the 
DNT test method and its ability to detect 
effects of concern from a regulatory perspec-
tive have been well established, the recent 
increase in the number of regulatory DNT 
studies being conducted has refocused atten-
tion on this test method. Although some 
argue that specific tests are insensitive (e.g., 
assessment of cognitive and sensory dysfunc-
tion), others suggest that the tests are overly 
sensitive and have a high rate of false positives 
(U.S. EPA 1995; Claudio et al. 1999, 2000; 
Cory-Slechta et al. 2001; U.S. EPA 2006). 
Diverse groups have advocated increased 
testing for DNT (Andersen et al. 2000; 
Grandjean and Landrigan 2006; NRC 1992, 
1993; Nelson 1986; Office of Technology 
Assessment 1990; Stein et al. 2002; Vorhees 
1986). There have also been calls to include 
evaluations of end points not currently 
assessed, such as social behavior (Cory-Slechta 
et al. 2001), pharmaco  kinetics and neuro-
chemistry (Andersen et al. 2000; Dorman 
et al. 2001), and changes during senescence 
(Cory-Slechta et al. 2001). In addition, there 
have been criticisms of the complexity of the 
study, accompanied by calls for deleting some 
test components from the protocol (Li 2005) 
or using screening approaches that incorpo-
rate DNT testing into other testing proto-
cols (Cooper et al. 2006; Ladics et al. 2005). 
Critics also claim that variability of some 
end points (e.g., motor activity, morpho-
metrics) is too great to be useful (Chemical 
Manufacturers Association 1987; Nolen 
1985; York et al. 2004) and that this in vivo 
test is not necessary to detect DNT (Balls 
and Combes 2005). These diverse opinions 
do not invalidate the DNT study but rather 
highlight the need for ongoing scientifically 
based evaluation of this test method and the 
incorporation of appropriate revisions as sci-
entific knowledge advances and as experience 
with the DNT study warrants.
A number of efforts are currently under 
way to review data from existing DNT stud-
ies, identify ways to refine the DNT test, and, 
if possible, reduce the number of animals 
used. It has been proposed that a reduction 
in animal use can be achieved by applying 
certain statistical approaches to the behav-
ioral analysis (Chiarotti and Puopolo 2000; 
Puopolo 2004). Reviews of historical and 
positive control data have demonstrated 
the need for more standardized reporting 
requirements (Crofton et al. 2004, 2008). 
Further retrospective reviews of control data 
have identified differences among laborato-
ries in data quality and variability, suggest-
ing methods to decrease variability (Crofton 
et al. 1991, 2004; Raffaele et al. 2003, 2004; 
Sette et al. 2004). Conversely, a review of 
various neuropathology assessments (e.g., 
brain weight, standard histopathology, and 
morphometric assessments) identified low 
variability for these measures (Crofton et al. 
2001), concluding that no one postmortem 
measure is more sensitive, with each provid-
ing important data (Raffaele et al. 2005). 
The outcome of this continuing effort will 
allow better data interpretation, help refine 
requirements for future testing, and guide 
new methods development.
In addition to the goal of refinement of 
the current approach to DNT testing, there 
is another and more pressing driver of change 
in the science arena of DNT. Currently, 
thousands of chemicals lack even simple, 
basic toxi  cologic data (e.g., high-production-
volume chemicals, pesticide inert ingredi-
ents, antimicrobial pesticides) but have a high 
potential for human exposure (NRC 1984). 
Assessing potential neurotoxicologic effects for 
these chemicals is a major challenge confront-
ing the chemical industry, international and 
national regulatory agencies, and associated 
stakeholders (Dix et al. 2007; Kavlock et al. 
2008; NRC 2007). New tools and methods 
are required to move toward a more sustain-
able risk assessment paradigm for these types 
of chemicals. Although the current DNT 
guidelines generate useful data for risk assess-
ment purposes, this in vivo test is costly and 
time-consuming and uses a relatively large 
number of naive animals when conducted as 
a stand-alone study (compared with incorpo-
rating the DNT testing into other protocols, 
e.g., as proposed in Cooper et al. 2006 and 
U.S. EPA 2002b). A pressing goal of future 
research is to develop a validated true first-tier 
screening paradigm (e.g., a high-throughput 
in vitro screening battery) that can rapidly 
screen large numbers of chemicals for their 
potential to cause DNT (Coecke et al. 2007; 
Lein et al. 2007; NRC 2007; U.S. EPA 
2006). Coupled with development of deci-
sion frameworks (e.g., Combes et al. 2003), 
data from these high-throughput screens may 
Table 4. Examples of chemicals and other stressors tested using the U.S. EPA DNT guideline or 
OECD TG 426.a
Abamectin  Dichlorvos (2)  Methyl parathion
Acephate  Dicrotophos  Methylazoxymethanol (2)
Acetamiprid  Dietary restriction  Methylmercury
Acibenzolar-s-methyl  Dimethoate  n-Methylneodecanamide
Acrylamide  Disulfoton  Molinate
AE-0172747  Emamectin  Naled
Aldicarb  Epidermal growth factor  Nelfinavir
Alitame  s-Ethyldipropylthiocarbamate  Nitrous oxide
Amicarbazone  Ethoprophos  Octamethylcyclotetrasiloxane
Atorvastatin  Ethylbenzene  Perchlorate
Azinphos methyl  Etofenprox  Phorate (2)
BAS 510F  Fenamidone  Prochloraz
BAS 670H  Fenamiphos  Profenofos
Bifenthrin  Fentin hydroxide   Propylthiouracil (2)
Carbaryl  Fipronil  Pymetrozine
Carbofuran  Flubendiamide  Pyrasulfotole
Chlorfenapyr  Flufenacet  Spirodiclofen
Chlorite, sodium  Glufosinate ammonium  Prothioconazole
Chlorpyrifos  Glyphosate trimesium  Styrene
CI-943  GN1180 (MN rgp120/HIV-1)  Tetrabromobisphenol A
Cigarette smoke  Hydrogen sulfide  Tebuconazole
Clodinafop propargyl  Imidacloprid  Terbufos
Clothianidin  Iminodiproprionitrile  Tetrachlorvinphos
Coumaphos  Indoxacarb  Thiamethoxam
Cyclohexanemethanol  Isopropanol  Thiocloprid
λ-Cyhalothrin  Isoxaflutole  Thiram
β-Cyfluthrin  Lead nitrate  Triallate
Cymoxanil  Lindane  Tribufos
ϑ-Cypermethrin  Malathion  Trichlorfon
Decamethylcyclopentasiloxane  Maternal separation  1,1,1-Trichloroethane
p,p-DDT  Methamidaphos  Trichloroethylene
DEET (N,N-diethyl-meta-toluamide)  p-Methane-3,8-diol  Triethylene glycol monomethyl ether
Deltamethrin  Methimazole (6)  Trimethyltin
Diazepam  Methyl bromide  Ziram
Diazinon
aNumbers indicate the number of studies conducted for that chemical.DNT: retrospective performance assessment
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facilitate prioritization of any further test-
ing in vivo, for example, as for substances 
identified as potentially hazardous under 
the European regulation on Registration, 
Evaluation, Authorisation, and Restriction of 
Chemical Substances (REACH) (European 
Commission 2006). Data generated by the 
current DNT test method will be vital in the 
validation of these high-throughput in vitro 
methods, providing information on their 
utility and limits, as well as guidance on the 
potential use of data from these alternative 
methods in a risk assessment context.
Conclusions
The OECD DNT TG 426 (OECD 2007) rep-
resents the best available science for assessing 
the potential for DNT in human health risk 
assessment, and data generated by DNT stud-
ies are relevant and reliable for this assessment. 
The test methods used in the DNT have been 
subjected to an extensive history of interna-
tional validation, peer review, and evaluation 
that is contained in the public record. The 
reproducibility, reliability, and sensitivity of 
these methods have been demonstrated, using 
a wide variety of test substances. Multiple, 
independent, expert scientific peer reviews 
affirm these conclusions, as described in this 
document. The OECD DNT TG 426 pro-
vides an outline of behavioral domains and 
morphologic end points, relevant to human 
neurodevelopment, that should be examined 
to assess potential DNT of a test compound. 
The results from DNT studies are used for 
hazard/risk assessment purposes, and in cases 
where data from a DNT study are not avail-
able, additional uncertainty factors may be 
employed by regulators to address the need 
for DNT data from a regulatory standpoint. 
This document shows that a variety of chemi-
cals have been tested for DNT, constituting 
a sampled spectrum of the chemical universe 
that the test is proposed to investigate. Several 
published reports outlined herein show that 
the DNT study is robust and can be con-
ducted in multiple laboratories with consistent 
performance.
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